Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA-650 (Infliximab) dose escalation in rheumatoid arthritis
NCT00691028Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Sep 2005
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in rheumatoid arthritis (RA), sponsored by Mitsubishi Tanabe Pharma. Started Sep 2005; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00691028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691028.